Congressman Fattah lends full support to The Pancreatic Cancer Research and Education Act

NewsGuard 100/100 Score

Congressman Fattah releases the following statement in observance of Pancreatic Cancer Awareness Month

"Pancreatic cancer is a rare and perplexing disease, yet it is the fourth leading cause of death by cancer in the United States. This year, more than 42,000 Americans will be diagnosed with the disease and more than 35,000 will die from it. That number is far too high.

"To find a cure for pancreatic cancer researchers have to know more about this disease. That is why I am lending my full support to H.R. 7045, The Pancreatic Cancer Research and Education Act. The legislation is the first of its kind to call for a significant infusion of funds for research and education concerning this killer cancer.

"I join the millions of American families affected by pancreatic cancer as well as our finest medical researchers in their journey to learn more about the disease with the hope that knowledge will ultimately lead to a cure.

"My family knows personally the devastation pancreatic cancer causes as it robbed my father-in-law, Elmer Chenault, of his life just over a year ago. My wife, Renee Chenault-Fattah, will join thousands from around the country as they walk in observance of Pancreatic Cancer Awareness Month knowing that each step gets us closer to finding a cure."

Source:

Office of Congressman Chaka Fattah

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Innovative breast cancer treatment sequence yields positive results